Agios Pharmaceuticals Stock News

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of 65.29% and 182.24%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of 65.29% and 182.24%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Agios Pharmaceuticals Inc:

Agio, a leading provider of cybersecurity and managed IT services, announces the division of Agio Healthcare, exclusively dedicated to offering the company's portfolio suite of cybersecurity services

CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $40.3 million in its first quarter. The Cambridge, Massachusetts-based company said it had a loss of 59 cents p

CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $40.3 million in its first quarter. The Cambridge, Massachusetts-based company said it had a loss of 59 cents p

Agios Pharmaceuticals sees cash, cash equivalents sufficient through June 2022 AGIO

Agios Pharmaceuticals updates status of clinical programs AGIO

Agios Pharmaceuticals expects delays in clinical programs AGIO

Agios Pharmaceuticals reports Q1 EPS (59), consensus ($1.67) AGIO

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu

Agios Pharmaceuticals, Inc. (AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today reported business highlights and financial results for the first quart

– First Quarter TIBSOVO® Net Revenue of $22.7 Million; Company Reiterates 2020 TIBSOVO® Net U.S. Revenue Guidance of $105–115 Million – – New Clinical...

Agios Pharmaceuticals files automatic mixed securities shelf AGIO

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) • Arvinas Inc (NASDAQ...